High sensitivity C-reactive protein level in cerebrovascular accident


  • Sonal Rajesh Kumar Consultant, Amrit Hospital, Sowcarpet, Chennai, Tamil Nadu, India
  • T. A. Vidya Department of Medicine, SRM Medical College Hospital and Research Centre, SRM IST, Kattankulathur, Kanchipuram District, Tamil Nadu, India




Hemorrhagic stroke, High sensitivity C-reactive protein, Ischemic stroke, Modified rankin scale


Background: Stroke is the second leading cause of death worldwide according to WHO. High sensitivity C-Reactive Protein (hs-CRP) is an acute phase reactant which is being studied extensively to delineate its role in development of stroke as well as in prognostication.  This study was done to assess correlation of hs-CRP with risk factors of stroke and its association with types of stroke and prognosis.

Methods: A prospective case control study of 100 patients with acute stroke along with 100 controls was conducted with informed consent.  At baseline, hs-CRP levels were measured and Modified Rankin Scale (MRS) was assessed. On day 90 the Modified Rankin Scale was assessed again. Patients were divided into groups based on hs-CRP levels and MRS and the results were analysed.

Results: Prevalence of stroke was more in men than women (p=0.0002).  Statistically significant difference was found between mean hs-CRP levels in men (4.722±0.8982 mg/L) and women (4.133±0.9446 mg/L) (p=0.005) and between cases and controls (p=0.0003). There was no significant association with type of stroke (p=0.456).  Mean total cholesterol levels between cases and controls showed statistically significant difference (p=0.0005). High MRS was significantly associated with high hs-CRP levels (p=0.003).  Higher hs-CRP on day 1 correlated with higher MRS on day 90.

Conclusions: hs-CRP level is increased in stroke and shows significant association with severity of stroke and prognosis.


Warlow C, Sudlow C, Dennis M, Wardlaw J, Sandercock P. Stroke. Lancet 2003;362(9391): 1211-24.

Johnston SC, Mendis C, Mathers CD. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol. 2009 Apr;8(4):345-54.

Feigin VL, Forouzanfar MH, Krishnamurti R, Mensah GA, Connor M, Bennett DA. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383(9913):245-54.

Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009 Apr;8(4):355-69.

Appelros P, Stegmayr B, Terént A. Sex differences in stroke epidemiology: a systematic review. Stroke. 2009 Apr 1;40(4):1082-90.

Holroyd-Leduc JM, Kapral MK, Austin PC, Tu JV. Sex differences and similarities in the management and outcome of stroke patients. Stroke. 2000 Aug;31(8):1833-7.

Indian Council for Medical Research. Stroke. In: Assessment of the burden of non-communicable diseases: Final project report. New Delhi: ICMR. 2004:18-22.

Govt. of India (2011), National Health Profile 2011, Ministry of Health andFamily Welfare, New Delhi. Available at: https://www.cbhidghs.nic.in/index1.php?lang=1&level=2&sublinkid=82&lid=77.

Neaton JD, Wentworth DN, Cutler J, Stamler J, Kuller L. Risk factors for death from different types of stroke. Annals Epidemiol. 1993 Sep 1;3(5):493-9.

Jia L, Hao F, Wang W, Qu Y. Circulating miR‐145 is associated with plasma high‐sensitivity C‐reactive protein in acute ischemic stroke patients. Cell Biochem Func. 2015 Jul;33(5):314-9.

Muir KW, Tyrrell P, Sattar N, Warburton E. Inflammation and ischaemic stroke. Curr Opin Neurol. 2007 Jun;20(3):334-42.

Packard RR, Libby P. Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction. Clin Chem. 2008 Jan;54(1):24-38.

Youn CS, Choi SP, Kim SH, Oh SH, Jeong WJ, Kim HJ, et al. Serum highly selective C-reactive protein concentration is associated with the volume of ischemic tissue in acute ischemic stroke. Am J Emerg Med. 2012 Jan;30(1):124-8.

Vibo R, Kõrv J, Roose M, Kampus P, Muda P, Zilmer K, et al. Acute phase proteins and oxidised low density lipoprotein in association with ischemic stroke subtype, severity and outcome. Free Radic Res. 2007 Mar;41(3):282-7.

Tu WJ, Dong X, Zhao SJ, Yang DG, Chen H. Prognostic value of plasma Neuroendocrine biomarkers in patients with Acute Ischemic stroke. J Neuroendocrinol. 2013 Sep;25(9):771-8.

Song IU, Kim JS, Kim YI, Lee KS, Jeong DS, Chung SW. Relationship between High-Sensitivity C-ReactiveProtein and Clinical Functional Outcome after Acute Ischemic Stroke in a Korean Population. Cerebrovasc Dis. 2009;28:545-50.

Whiteley W, Jackson C, Lewis C, Lowe G, Rumley A, Sandercock P, et al. The association of circulating inflammatory markers with recurrent vascular events after stroke: a prospective cohort study. Stroke. 2011 Jan;42(1):10-6.

Wang Q, Ding H, Tang JR, Zhang L, Zu YJ, Yan JT, et al. C-reactive protein polymorphisms and genetic susceptibility to ischemic stroke and hemorrhagic stroke in the Chinese Han population. Acta Pharmacol Sin. 2009;30(3):291-8.

Wakugawa Y, Kiyohara Y, Tanizaki Y, Kubo M, Ninomiya T, Hata J, et al. C-reactive protein and risk of first-ever ischemic and hemorrhagic stroke in a general Japanese population: the Hisayama Study. Stroke. 2006 Jan 1;37(1):27-32.

Andersson J, Johansson L, Ladenvall P, Wiklund PG, Stegmayr B, Jern C, et al. C-reactive protein is a determinant of first-ever stroke: prospective nested case-referent study. Cerebrovas Dis. 2009;27(6):544-51.

Di Napoli M, Papa F, Bocola V. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke. 2001 Jan;32(1):133-8.

Specifications Manual for Joint Commission National Quality Measures (v2016B). Available at: https://manual.jointcommission.org/releases/TJC2016B/DataElem0569.html. Accessed 1 July 2017.

WHO Statistical Resources, India. Available at https://www.cdc.gov/globalhealth/countries/india/default.htm

Patgiri D, Pathak MS, Sharma P, Kutum T, Mattack N. Serum hsCRP: A Novel Marker for Prediction of Cerebrovascular Accidents (Stroke). J Clin Diagn Res. 2014 Dec;8(12) CC08-CC11.

Elkind MS, Coates K, Tai W, Paik MC, Boden-Albala B, Sacco RL. Levels of acute phase proteins remain stable after ischemic stroke. BMC Neurol. 2006 Dec 1;6(1):37.

Taheraghdam A, Aminnejad S, Pashapour A, Rikhtegar R, Ghabili K. Is there a correlation between hs-CRP levels and functional outcome of Ischemic Stroke?. Pak J Medical Sci. 2013 Jan;29(1):166-9.

O‘Malley T, Langhorne P, Elton R, Stewart C. Platelet size in stroke patients. Stroke. 1995;26(6):995-9.

Pikija S, Cvetko D, Hajduk M, TrkuljaV . Higher mean platelet volume determined shortly after the symptom onset in acute ischemic stroke patients is associated with a larger infarct volume on CT brain scan sand with worse clinical outcome. Clini Neurol Neurosurg. 2009;111(7):568-73.

Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999;340(23):1801-11.

Lal R, Gupta A, Virmani SK, kumar Tyagi V, Sharma S. High sensitivity C-reactive protein as a prognostic marker in ischaemic and haemorrhagic stroke. Inter J Adv Med. 2016 Apr;3(2):372.

Mishra PT, Chandra R, Saxena SK, Verma S, Jain R, Bhuyan A. High sensitivity c-reactive protein (hsCRP) level in cerebrovascular accident (Stroke). Age (yrs). 2010;58:52-76.

Idicula TT, Brogger J, Naess H, Waje-Andreassen U, Thomassen L. Admission C–reactive protein after acute ischemic stroke is associated with stroke severity and mortality: The 'Bergen stroke study'. BMC neurology. 2009 Dec;9(1):18.

Elkind MS, Luna JM, Moon YP, Liu KM, Spitalnik SL, Paik MC, et al. High-sensitivity C-reactive protein predicts mortality but not stroke: the Northern Manhattan Study. Neurol. 2009 Oct20; 73(16):1300-7.

Chaudhuri JR, Mridula KR, Umamahesh M, Swathi A, Balaraju B, Bandaru VSS. High sensitivity C-reactive protein levels in Acute Ischemic Stroke and subtypes: A study from a tertiary care center. Iran J Neurol. 2013;12(3):92-7.

Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR. C-reactive protein and outcome after ischemic stroke. Stroke. 1999;30(5):981-5.

den Hertog HM, van Rossum JA, van der Worp HB, van Gemert HM, de Jonge R, Koudstaal PJ, et al. C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death. J Neurol. 2009; Dec 256(12):2003-8.






Original Research Articles